Search
for
Sort by
Research 30 of 350
- Roles of steroid receptors in the lung and COVID-19
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review
- Pathobiology questions raised by telogen effluvium and trichodynia in COVID‐19 patients
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility
- Comment on “Androgens and women: COVID‐19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism”
- Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity
- COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
- Skin Tissue: A Place for SARS-CoV-2 to Multiply and Transmit?
- The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them?
- Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated?
- A response to “Male balding is a major risk factor for severe COVID-19”
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
- Genetic and hormonal influence on SARS-CoV-2-infection susceptibility
- TMPRSS2, required for SARS-CoV-2 entry, is downregulated in lung cells by enzalutamide, a prostate cancer therapeutic
- Enzalutamide, a prostate cancer therapeutic, downregulates TMPRSS2 in lung and reduces cellular entry of SARS-CoV-2
- SARS‐CoV‐2 & androgenic alopecia: exploring links!
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
- Sex Hormones in COVID-19 Severity: The Quest for Evidence and Influence Mechanisms
- Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
- Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels
- Role of Polycystic Ovary Syndrome in Increasing Susceptibility to COVID-19: A Biochemical and Psychological Approach
- Testosterone in COVID-19: An Adversary Bane or Comrade Boon
- Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system
- Extrapulmonary manifestations of coronavirus disease (COVID-19): current status (a literature review)